Literature DB >> 8611670

Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues.

S Romain1, F Spyratos, C Lainé-Bidron, C Bouchet, O Guirou, P M Martin, J Oglobine, H Magdelénat.   

Abstract

The urokinase type plasminogen activator (u-PA) and the plasminogen activator inhibitor-1 (PAI-1) are among the best second-generation prognostic tissue factors in breast cancer. However, different extraction procedures and assay kits are used in different laboratories. A total of 79 breast tumour tissues stored in liquid nitrogen were analysed in this study. We compared u-PA and PAI-1 levels determined with the American Diagnostics (AD) kit after various extraction procedures. The median cytosolic extraction yield in the presence of 0.4 mol/l KCl, calculated relative to extraction in the presence of 10 ml/l Triton X100 when adapted to standard laboratory working hours (incubation for 2 h instead of 12 h) was 74.4% for u-PA and 85.8% for PAI-1. In addition, the correlations were acceptable. Cytosolic extracts prepared with KCl could permit optimal u-PA and PAI-1 assays while also enabling hormone receptors to be determined with the same specimens. Further studies with clinical data are now necessary to determine the prognostic relevance of this extraction procedure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8611670

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  3 in total

1.  Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues.

Authors:  C Bouchet-Bernet; F Spyratos; C Andrieu; S Deytieux; V Bécette; J Oglobine
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.

Authors:  J Y Pierga; C Lainé-Bidron; P Beuzeboc; P De Crémoux; P Pouillart; H Magdelénat
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts.

Authors:  C G Sweep; J Geurts-Moespot; N Grebenschikov; J H de Witte; J J Heuvel; M Schmitt; M J Duffy; F Jänicke; M D Kramer; J A Foekens; N Brünner; G Brugal; A N Pedersen; T J Benraad
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.